找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Metastatic Bone Disease; An Integrated Approa R. Lor Randall Book 2024Latest edition The Editor(s) (if applicable) and The Author(s), under

[復(fù)制鏈接]
查看: 26926|回復(fù): 58
樓主
發(fā)表于 2025-3-21 18:38:44 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱Metastatic Bone Disease
副標(biāo)題An Integrated Approa
編輯R. Lor Randall
視頻videohttp://file.papertrans.cn/632/631758/631758.mp4
概述Covers all aspects of surgical and medical intervention in metastatic bone disease.Presents biology, work-up, medical therapy, radiation and interventional oncology, and more.Features rich and detaile
圖書(shū)封面Titlebook: Metastatic Bone Disease; An Integrated Approa R. Lor Randall Book 2024Latest edition The Editor(s) (if applicable) and The Author(s), under
描述.Skeletally related events make up approximately 20% of the cancer care economy. Advances in understanding the pathobiology and better biotargeted therapy and improved surgical technology are occurring continuously. Hundreds of thousands of patients are living longer with ever-increasing tumor burden, but patients can remain siloed in their care as they navigate across subspecialty treatments.?This comprehensive text ties it all together around the patient, integrating all aspects of care..Providing an integrated approach to the diagnosis and management of patients with metastatic bone disease (MBD), this revised and expanded text combines discussion of the pathobiology of the disease with the latest oncological and orthopedic treatment modalities. After opening with an examination of the epidemiology and impact of MBD, the biology of bone metastases are discussed, along with considerations of the tissue of origin, evaluation, biopsy andmedical therapy, including metabolic agents and biotargeting. The heart of the book presents oncological approaches (supportive, radiation and interventional) and principles of orthopedic surgical oncology, with subsequent chapters covering specific
出版日期Book 2024Latest edition
關(guān)鍵詞Ablation technologies; Biotargeting; Bisphosphonates; Bone cancer; Bone tumor; Cement augmentation; Interv
版次2
doihttps://doi.org/10.1007/978-3-031-52001-3
isbn_softcover978-3-031-52003-7
isbn_ebook978-3-031-52001-3
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書(shū)目名稱Metastatic Bone Disease影響因子(影響力)




書(shū)目名稱Metastatic Bone Disease影響因子(影響力)學(xué)科排名




書(shū)目名稱Metastatic Bone Disease網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Metastatic Bone Disease網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Metastatic Bone Disease被引頻次




書(shū)目名稱Metastatic Bone Disease被引頻次學(xué)科排名




書(shū)目名稱Metastatic Bone Disease年度引用




書(shū)目名稱Metastatic Bone Disease年度引用學(xué)科排名




書(shū)目名稱Metastatic Bone Disease讀者反饋




書(shū)目名稱Metastatic Bone Disease讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:22:52 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:26:24 | 只看該作者
Book 2024Latest editionrapy and improved surgical technology are occurring continuously. Hundreds of thousands of patients are living longer with ever-increasing tumor burden, but patients can remain siloed in their care as they navigate across subspecialty treatments.?This comprehensive text ties it all together around t
地板
發(fā)表于 2025-3-22 08:02:35 | 只看該作者
5#
發(fā)表于 2025-3-22 11:38:15 | 只看該作者
6#
發(fā)表于 2025-3-22 16:27:39 | 只看該作者
Introduction to Multiple Myeloma and Multiple Myeloma Bone Diseasecies (Perrot 2022). There will be an estimated 12,640 deaths from MM in 2022. MM has an incidence of 7.1 per 100,000 in the US per year, with higher incidence among non-Hispanic blacks. The estimated prevalence of the disease as of 2019 was 159,787 [3].
7#
發(fā)表于 2025-3-22 18:38:57 | 只看該作者
Evaluation of the Patient with Carcinoma of Unknown Origin Metastatic to Boneinoma or to rule out primary bone sarcomas. Patients who present with a displaced pathologic fracture require an urgent diagnostic and treatment plan that does not compromise future treatment options and provides durable skeletal reconstruction.
8#
發(fā)表于 2025-3-23 00:04:32 | 只看該作者
9#
發(fā)表于 2025-3-23 02:41:44 | 只看該作者
Tissue Engineered Models to Study Bone Metastasis and Metastatic Bone Diseaseon continues to age, MBD rates are expected to increase, resulting in greater economic burden, lower survival rates, and worse clinical outcomes as resources for treatment become strained. Therefore, there is a direct need for improved clinical treatment to enhance survival rates and improve outcomes.
10#
發(fā)表于 2025-3-23 08:30:49 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 12:01
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
铜鼓县| 永善县| 荔波县| 疏勒县| 麻江县| 凤山市| 庐江县| 宁晋县| 蓝山县| 金阳县| 景德镇市| 招远市| 休宁县| 定兴县| 布尔津县| 阳泉市| 江油市| 顺昌县| 盐城市| 合作市| 呼图壁县| 叙永县| 涟源市| 定陶县| 高唐县| 崇文区| 焦作市| 攀枝花市| 巴林左旗| 潜山县| 嵊州市| 缙云县| 海原县| 两当县| 灌云县| 江永县| 寻乌县| 凯里市| 南通市| 舟山市| 雅安市|